Clogbusting: Time for a concerted approach to catheter occlusions?

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 8, Issue 3, 2005, Pages 277-283

  Hardy, Gil ^a   Ball, Patrick ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b CHARLES STURT UNIVERSITY   (Australia)

Author keywords

Blockage; Central venous catheter; Complications; Infection; Occlusion; Venous access

Indexed keywords

ALTEPLASE; ANTIINFECTIVE AGENT; DIAZEPAM; EDETIC ACID; ETOPOSIDE; FIBRINOLYTIC AGENT; GLUCONATE CALCIUM; HEPARIN; PHENYTOIN; PROTAMINE SULFATE; RETEPLASE; STREPTOKINASE; TOBRAMYCIN; UROKINASE; WARFARIN;

CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; DRUG COST; DRUG SAFETY; HEALTH CARE ORGANIZATION; HUMAN; INFECTION; LIPID STORAGE; LOW DRUG DOSE; NUTRITIONAL SUPPORT; OCCLUSION; ONCOLOGY; PNEUMONIA; PRECIPITATION; REVIEW; SEPSIS; STAPHYLOCOCCUS EPIDERMIDIS; THROMBOCYTOPENIA; THROMBOGENESIS; THROMBOPHLEBITIS; THROMBOSIS; VASCULAR ACCESS;

THROMBUS;

EID: 17844396480     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mco.0000165006.39449.1f     Document Type: Review

References (64)

1. Maki DG, Stolz SM, Wheeler S, et al. Prevention of central venous catheter-related blood-stream infection by use of an antiseptic-impregnated catheter. Ann Intern Med 1997; 127:226-257.
2. Waghorn DJ. Intravascular device associated systemic infections. J Hosp Infect 1994; 28:91-101.
3. Segura M, Alvarez-Lerma F, Tellado JM, et al. A clinical trial on the prevention of catheter related sepsis using a new hub model. Ann Surg 1996; 223:363-369.
4. Elliott TS. Line-associated bacteraemias. Commun Dis Rep CDR Rev 1993; 3:R91-R96.
5. Mermel LA. Preventive strategies for intravascular catheter-related infections. In: Waldvogel FA, Bisno AL, editors. Infections associated with indwelling medical devices 3rd ed. Washington, DC: ASM Press; 2000. pp. 407-425.
6. Raad II. Intravascular catheter related infections. Lancet 1998; 351:893-898.
7. Bierman S. Suture: an unlikely culprit in infections and accidental needle sticks. Manag Infect Control 2002; 12:44-46.
8. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep 2002; 51:1-26.
9. Beathard G. Catheter thrombosis. Semin Dial 2001; 14:411-445.
10. Stephens LC, Haire WD, Kotulak GD. Are clinical signs accurate indicators of the cause of CVC occlusion? J Parenter Enter Nutr 1995; 19:75-79.
11. Gray RJ, Levitin A, Buck D, et al. Percutaneous fibrin sheath stripping versus transcatheter urokinase infusion for malfunctioning well positioned tunnelled central venous dialysis catheters: a prospective, randomized trial. J Vasc Intervent Radiol 2000; 11:1121-1129.
12. Hyman G, England M, Kibede S, et al. The efficacy and safety of reteplase for thrombolysis of HD catheters at a community and academic regional medical center. Nephron Clin Pract 2004; 96:c39-c42.
13. Herbst SL, Kaplan LK, Mckinnon BT. Vascular access devices: managing occlusions and related complications in home infusion. Infusion 1998; 4:1-32.
14. Haire WD, Atkinson JB, Stephens LC, et al. Urokinase versus recombinant tissue plasminogen activator in thrombosed central venous catheters: a double-blind randomized trial. Thromb Haemost 1994; 72:543-547.
15. Deitcher SR, Fesen MR, Kiproff PM, et al. Safety and efficacy of alteplase in restoring function in occluded central venous catheters: results of the Cardiovascular Thrombolytic to Open Occluded Lines Trial. J Clin Oncol 2002; 20:317-324.
16. Ponec D, Irwin D, Haire WD, et al. Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo controlled trial. The Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial. J Vasc Radiol 2001; 12:951-955.
17. Jacobs BR, Haygood M, Hingl J. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children. J Pediatr 2001; 139:593-596.
18. Hurtubise MR, Bottino JC, Lawson M, et al. Restoring patency of occluded central venous catheters. Arch Surg 1980; 115:212-213.
19. Glyn MF, Langer B, Jeejeebhoy KN. Therapy for thrombotic occlusion of long-term intravenous alimentation catheters. J Parenter Enter Nutr 1980; 4:387-390.
20. Lawson M, Bottino JC, Hurtubise MR, et al. The use of urokinase to restore patency of occluded central venous catheters. Am J Intraven Ther Clin Nutr 1982; 9:29-32.
21. Wachs T. Urokinase administration in pediatric patients with occluded central venous catheters. J Intraven Nurs 1990; 13:100-102.
22. Raad II, Luna M, Khalil SM, et al. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 1994; 271:1014-1016.
23. Olson M, Lam K, Bodey GP, King EG. Evaluation of strategies for central venous catheter replacement. Crit Care Med 1992; 20:797-804.
24. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991; 338:339-343.
25. Fraschini E, Jadeja J, Lawson M, et al. Local infusion of urokinase for the lysis of thrombosis associated with permanent central venous catheters in cancer patients. J Clin Oncol 1987; 5:672-678.
26. Barzaghi A, Dell'Orto M, Rovelli A, et al. Central venous catheter clots: incidence, clinical significance and catheter care in patients with hematologic malignancies. Pediatr Hemost Oncol 1995; 12:243-250.
27. Anaissie E, Samonis G, Kontoyiannis D, et al. Role of catheter colonisation and infrequent hematogenous seeding in catheter-related infections. Eur J Clin Microbial Infect Dis 1995; 4:134-137.
28. Mermel LA, Maki DG. Infectious complications of Swan-Ganz pulmonary artery catheters. Am J Respir Crit Care Med 1994; 149:1020-1036.
29. Tebbs SE, Sawyer A, Elliot TSJ. Influence of surface morphology on in vitro bacterial adherence to central venous catheters. Br J Anaesth 1994; 72:587-591.
30. Bozzetti F, Scarpa D, Terno G, et al. Subclavian thrombosis due to indwelling catheters. J Parenter Enter Nutr 1983; 7:560-562.
31. Elliott TSJ, Faroqui MH. Infections and intravascular devices. Br J Hosp Med 1992; 48:496-503.
32. Jacobs BR, Schilling S, Doellman D, et al. Central venous catheter occlusion: a prospective controlled trial examining the impact of a positive-pressure valve device. J Parenter Enter Nutr 2004; 28:113-118. A valuble trial demonstrating the ability of positive pressure devices to reduce the rate of occlusions.
33. Prasad GS, Ledger R, Puntis JWL, Ball PA. Occluding material present in central venous and haemodialysis catheters. In: BAPEN Abstracts. Proc Nutr Soc 1998; 57:52.
34. Matthews E, Ledger R, Ball PA. A simple clotting model does not explain central venous line occlusion. In: Proceedings of the New Zealand Hospital Pharmacists Association. Wellington, 1998. p. 38.
35. Svoboda P, Barton P, Barbarash OL, et al. Recombinant urokinase is safe and effective in restoring patency to occluded central venous devices. Crit Care Med 2004; 32:1990-1996. A recent evaluation of the efficacy of recombinant urokinase in comparison with other forms.
36. Food and Drug Administration. Safety alert: hazards of precipitation associated with parenteral nutrition. Am J Hosp Pharm 1994; 51:427-429.
37. McKinnon BT. FDA safety alert: hazards of precipitation associated with parenteral nutrition. Nutr Clin Pract 1996; 11:59-65.
38. Mckinnon BT, Lima HA. Catheter occlusions: causes and solutions. Int J Pharm Comp 1998; 2:342-346.
39. Schmidt GL, Baumgartner TG, Fischlschwerger W, et al. Cost containment using cysteine HCI acidification to increase calcium/phosphate solubility in hyperalimentation solutions. J Parenter Enter Nutr 1986; 10:203-207.
40. Hardy G, Cotter R, Dawe R. The stability and comparative clearance of TPN mixtures with lipid. In: Johnson IDA, editor. Advances in clinical nutrition. London: MTP Press; 1982.
41. Werlin SL, Lausten T, Jessen S, et al. Treatment of central venous catheter occlusions with ethanol and hydrochloric acid. J Parenter Enter Nutr 1995; 19:416-418.
42. Thompson B, Veal D. Pharmacologic treatment of paediatric catheter occlusions. Hosp Pharm 1992; 27:137-141.
43. ter Borg F, Timmer J, der Kam SS, Saurwein HP. Use of sodium hydroxide solution to partially clear occluded vascular access ports. J Parenter Enter Nutr 1993; 17:289-291.
44. Goodwin ML. Using sodium bicarbonate to clear a medication precipitate from a central venous catheter. J Vasc Access Networks 1991; 1:23.
45. Fletcher SJ, Bodenham AR. Catheter-related sepsis: an overview. Br J Intens Care 1999; 9:46-53.
46. Dobbins BM, Kite P. Endoluminal brushing in catheter-related sepsis: a sweeping statement. Nutrition 1999; 15:66-67.
47. Cobb DK, High KP, Sawyer RG, et al. A controlled trial of scheduled replacement of central venous catheters. N Engl J Med 1992; 327:1062-1068.
48. Eyer S, Brummitt C, Crossley K, et al. catheter-related sepsis: a prospective randomised study. Crit Care Med 1990; 18:1073-1079.
49. Attar A, Messing B. Evidence-based prevention of catheter infection during parenteral nutrition. Curr Opin Clin Nutr Metab Care 2001; 4:211-218.
50. Ball PA, Brokenshire EM, Paul L, et al. Ethanol locks in the management of central venous catheter sepsis; review of seven cases. ESPEN Abstracts Clin Nutr 2003; 22(Suppl 1):S82.
51. Price PB. Ethyl alcohol as a germicide. Arch Surg 1939; 38:528-542.
52. Larson EL, Morton HE. Alcohols. In: Block SS, editor. Disinfection, sterilisation and preservation. Phildelphia: Lea and Febiger; 1991. pp. 191-203.
53. Pennington CR, Pithie AD. Ethanol lock in the management of catheter occlusion. J Parenter Enter Nutr 1987; 11:507-508.
54. Rai M, Dexter T. Intravascular catheters and sepsis. Care Crit III 2001; 17:21-25.
55. Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in central venous and pulmonary artery catheters; a meta analysis of randomised controlled studies. Chest 1998; 113:165-171.
56. Mudge B, Forcier D, Slattery MJ. Patency of 24 gauge peripheral intermittent infusion devices. Paediatr Nurs 1998; 24:142-145.
57. Zevola DR, Dioso J, Moggio R. Comparison of heparinized and nonheparinized solutions for maintaining patency of arterial and pulmonary catheters. Am J Crit Care 1997; 6:52-55.
58. Shah P, Shah V. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous CVC. Cochrane DataBase Syst Rev 2001; 3:CD002772.
59. Chowdbury SK, Parashar K. Central venous access in neonates through the peripheral route. Curr Opin Clin Nutr Metab Care 2000; 3:217-219.
60. Scottish HPN Managed Clinical Network. Available at: www.show.scot. nhs.uk/shpnmcn. 2004. Accessed: 17 January 2005. Extremely useful and detailed procedures for catheter care, infection control and catheter declogging techniques.
61. Bouza E, Burillo A, Munoz P. Catheter-related infections, diagnosis and intravascular treatment. Clin Microb Infect 2002; 8:265-274.
62. Kress L, Donoghue J. Catheter brushing has made a sweeping difference to our clinical practice. Nephrol Nurs J 2000; 27:403-405.
63. Catton JA, Dobbins BM, Woods JM, et al. The routine microbiological screening of central venous catheters in home parenteral nutrition patients. Clin Nutr 2004; 23:171-175.
64. Varella L. Prevention of PN infections. Silver Springs: ASPEN; 2005.